Genomic Sequencing for Evaluation of Fetal Structural Anomalies

NCT06054230•University of California, San Francisco

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Fetal Structural Anomalies

Interventions

Genomic Sequencer

Locations

United States

Locations (1)

University of California, San Francisco

San Francisco, California, United States

Key Dates

Start Date

September 18, 2023

Primary Completion Date

July 15, 2030

Completion Date

July 15, 2030

Last Updated

April 6, 2025

Sponsors

Lead Sponsor

University of California, San Francisco

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 6, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions